Atorvastatin with TB meds: a drug study for TB patients
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests if adding the cholesterol drug atorvastatin to standard TB treatment can help clear the infection faster. It looks at how the body processes the drugs and how well they work together.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your sputum test must show TB germs (Gene Xpert or smear positive)
- You must have either never taken TB drugs or taken them for less than 2 weeks
- You must be 12 years or older
- You must not have HIV
- You must not smoke tobacco or use it in any form
- You must not have other serious health problems like heart disease, diabetes, high blood pressure, or kidney problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding the cholesterol drug atorvastatin to standard TB treatment helps people recover faster. It is for people with newly diagnosed, drug-sensitive tuberculosis who have not yet started treatment.
This trial studies whether atorvastatin (a cholesterol medicine) can reduce ongoing inflammation after you finish standard tuberculosis (TB) treatment. If it works, it may improve how your body recovers after TB, especially by lowering inflammation-related signals.
This study is testing new combinations of drugs to treat tuberculosis (TB) in the lungs. It aims to find a more effective and shorter treatment, and you may benefit from receiving these new drugs while helping advance TB research.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
This trial tests new combinations of TB medicines for people with active lung TB that is sensitive to standard drugs. It aims to find safer, shorter treatments that work just as well or better than current options.
This study compares two different HIV medication regimens in people who have both HIV and active tuberculosis (TB) and are starting HIV treatment for the first time. The goal is to see which combination works better and is safer when taken together with TB medications.
Hear when a new Pulmonary Tuberculosis (TB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.